Cite
HARVARD Citation
Kearsley-Fleet, L. et al. (n.d.). P66 Adalimumab originator versus biosimilar in children and young people with JIA. Rheumatology advances in practice. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kearsley-Fleet, L. et al. (n.d.). P66 Adalimumab originator versus biosimilar in children and young people with JIA. Rheumatology advances in practice. p. . [Online].